Law360 Healthcare Authority
Sign In
 
Law360 Healthcare Authority
  • Advanced Search
  Sign In
Close
  • Law360
  • Law360
  • Law360 UK
  • Law360 Pulse
  • Law360 Employment Authority
  • Law360 Tax Authority
  • Law360 Insurance Authority
  • Law360 Real Estate Authority
  • Law360 Bankruptcy Authority
  • Sections
  • Home
  • Deals & Corporate Governance
  • Digital Health & Technology
  • Policy & Compliance
  • Other Healthcare News
  • Site Menu
  • Contact Us
  • Sign up for our newsletters
  • About Law360 Authority
Deals & Corporate Governance ··· Digital Health & Technology ··· Policy & Compliance ··· More

In re: Entresto (Sacubitril/Valsartan) Patent Litigation

Track this case

Case overview

Case Number:

1:20-md-02930

Court:

Delaware

Nature of Suit:

Patent - Abbreviated New Drug Application(ANDA)

Multi Party Litigation:

Multi-district Litigation

Judge:

Richard G. Andrews

Firms

  • Abrams & Bayliss
  • Duane Morris
  • Heyman Enerio
  • Kratz & Barry
  • McCarter & English
  • Morris James
  • Parker Poe
  • Perkins Coie
  • Phillips McLaughlin
  • Pinckney Weidinger
  • Potter Anderson
  • Richards Layton
  • Schrader Companion
  • Shaw Keller
  • Smith Katzenstein
  • Stamoulis & Weinblatt
  • Steptoe & Johnson PLLC
  • Venable LLP
  • Young Conaway

Companies

  • Alembic
  • Alembic Pharmaceuticals Ltd.
  • Alkem Laboratories Ltd.
  • Aurobindo Pharma Ltd.
  • Biocon Ltd.
  • Dr. Reddy's Laboratories Ltd.
  • Hetero Labs Ltd.
  • Laurus Labs Pvt Ltd.
  • Lupin Ltd.
  • Macleods Pharmaceuticals Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Torrent Pharmaceuticals Ltd.
  • Viatris Inc.
  • Zydus Pharmaceuticals Inc.

Sectors & Industries:

  • Healthcare
    • Biotechnology
    • Generic
    • Major
    • Medical Instruments & Supplies
    • Other
  1. September 28, 2022

    Novartis Gets Counterclaims Cut From Heart Drug Patent MDL

    A Delaware federal judge has thrown out declaratory judgment counterclaims lodged against Novartis by two generic-drug makers in multidistrict patent litigation over Novartis' heart medication Entresto, determining that the court lacks subject matter jurisdiction.

    • ← Previous
    • 1
    • 2
    • Next →
RELX Group Lexis Nexis

© 2025, Portfolio Media, Inc. | About Healthcare Authority | Contact Us | Advertise with Law360 | Terms | Privacy Policy | Cookie Settings | Ad Choices